Cargando…
Development of alternative gene transfer techniques for ex vivo and in vivo gene therapy in a canine model
INTRODUCTION: Gene therapy have recently attracted much attention as a curative therapeutic option for inherited single gene disorders such as hemophilia. Hemophilia is a hereditary bleeding disorder caused by the deficiency of clotting activity of factor VIII (FVIII) or factor IX (FIX), and gene th...
Autores principales: | Noda, Masashi, Tatsumi, Kohei, Matsui, Hideto, Matsunari, Yasunori, Sato, Takeshi, Fukuoka, Yasushi, Hotta, Akitsu, Okano, Teruo, Kichikawa, Kimihiko, Sugimoto, Mitsuhiko, Shima, Midori, Nishio, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441024/ https://www.ncbi.nlm.nih.gov/pubmed/34584911 http://dx.doi.org/10.1016/j.reth.2021.08.009 |
Ejemplares similares
-
A Novel Cell-Sheet Technology That Achieves Durable Factor VIII Delivery in a Mouse Model of Hemophilia A
por: Tatsumi, Kohei, et al.
Publicado: (2013) -
Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A
por: Matsui, Hideto, et al.
Publicado: (2014) -
Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
por: Fraldi, Alessandro, et al.
Publicado: (2018) -
In Vivo and Ex Vivo Gene Electrotransfer in Ophthalmological Disorders
por: Fusco, Roberta, et al.
Publicado: (2022) -
Ex Vivo Prefabricated Rat Skin Flap Using Cell Sheets and an Arteriovenous Vascular Bundle
por: Fujisawa, Daisuke, et al.
Publicado: (2015)